Umea, Sweden

Emma Andersson

This inventor holds 1 USPTO granted patent. Top assignee: Eirium Ab. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Emma Andersson. Retrieved from https://idiyas.com/inventor/emma-andersson-p907y6r3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Emma Andersson - Innovator in Antiviral Compounds

Introduction

Emma Andersson is a prominent inventor based in Umeå, Sweden. She has made significant contributions to the field of antiviral research, particularly focusing on the development of new compounds that can combat viral infections. Her work is crucial in the ongoing battle against viruses that affect human health.

Latest Patents

Emma holds a patent for antiviral compounds, which provides new pharmacological compositions aimed at the prophylaxis, prevention, and treatment of viral infections. This invention specifically targets adenovirus and herpes virus infections, showcasing her commitment to advancing medical science and improving patient outcomes. She has 1 patent to her name.

Career Highlights

Throughout her career, Emma has demonstrated exceptional skill and dedication in her research. Her innovative approach to developing antiviral compounds has positioned her as a key figure in her field. She works at Eirium AB, a company that focuses on cutting-edge pharmaceutical solutions.

Collaborations

Emma collaborates with talented individuals such as Karin Edlund and Christopher Öberg. These partnerships enhance her research efforts and contribute to the success of her projects.

Conclusion

Emma Andersson is a remarkable inventor whose work in antiviral compounds is making a significant impact in the medical field. Her dedication to innovation and collaboration continues to drive advancements in the treatment of viral infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…